ABBV

In April 2026, AbbVie's shares increased to $214.14, reaching a 4-week high, but also saw decreases to 35-week and 33-week lows. On April 29, 2026, AbbVie reported strong first-quarter 2026 financial results, exceeding expectations and leading to a more than 3% intraday rise in shares. In May 2026, AbbVie announced a quarterly dividend of $1.73 per share. On May 9, 2026, AbbVie reported record 2025 results at its annual meeting, with total net revenues of $61.2 billion and adjusted EPS of $10.54.